NCT04604041View on ClinicalTrials.gov

Investigation of Subclinical Markers of Multiple Sclerosis

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2028

Conditions
Multiple SclerosisRelapsing Remitting Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

1. Clinical testing; 2. Neurophysiological examination (TMS, EMNG); 3. Psychomotor examination; 4. Neuropsychological evaluation; 5. Flow cytometry; 6. ELISA

All groups will not have the same intervention. Interventions are listed and numbered for each group.

Trial Locations (1)

21000

RECRUITING

University of Split School of Medicine, Split

All Listed Sponsors
collaborator

University Hospital of Split

OTHER

lead

University of Split, School of Medicine

OTHER